We are live on
!
Find out more
PBM
Propel Bio Management Portfolio holdings
AUM
$159M
1-Year Est. Return
60.94%
This Fund
S&P 500
This Quarter
Est. Return
+0.98%
1 Year Est. Return
+60.94%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$86.1M
AUM Growth
-$14.6M
(-15%)
Cap. Flow
-$9.23M
Cap. Flow
% of AUM
-10.72%
Top 10 Holdings %
Top 10 Hldgs %
91.73%
Holding
23
New
2
Increased
4
Reduced
2
Closed
5
Top Buys
| 1 |
Milestone Pharmaceuticals
MIST
|
+$2.89M |
| 2 |
Delcath Systems
DCTH
|
+$2.28M |
| 3 |
APLT
Applied Therapeutics
APLT
|
+$983K |
| 4 |
Phathom Pharmaceuticals
PHAT
|
+$880K |
| 5 |
Compass Therapeutics
CMPX
|
+$607K |
Top Sells
| 1 |
AKRO
Akero Therapeutics
AKRO
|
+$4.87M |
| 2 |
Ardelyx
ARDX
|
+$4.82M |
| 3 |
Madrigal Pharmaceuticals
MDGL
|
+$4.27M |
| 4 |
Kymera Therapeutics
KYMR
|
+$2.27M |
| 5 |
Kura Oncology
KURA
|
+$1.13M |
Sector Composition
| 1 | Healthcare | 67.17% |
| 2 | Energy | 31.57% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Plains GP Holdings
PAGP
$4.97B
| $27.2M | 31.57% |
1,272,360
| – | – |
|
|
2
Madrigal Pharmaceuticals
MDGL
$12.7B
| $9.95M | 11.56% |
30,032
-13,000
| -30% | -$4.27M |
|
|
AKRO
3
DELISTED
Akero Therapeutics
AKRO
| $9.27M | 10.76% |
228,884
-114,845
| -33% | -$4.87M |
|
|
4
Phathom Pharmaceuticals
PHAT
$881M
| $7.12M | 8.27% |
1,134,927
+145,000
| +15% | +$880K |
|
5
Achieve Life Sciences
ACHV
$650M
| $6.55M | 7.61% |
2,453,092
| – | – |
|
|
APLT
6
DELISTED
Applied Therapeutics
APLT
| $5.52M | 6.41% |
11,285,420
+1,670,000
| +17% | +$983K |
|
|
RNAM
7
DELISTED
Avidity Biosciences
RNAM
| $5.27M | 6.12% |
178,500
| – | – |
|
8
Abeona Therapeutics
ABEO
$415M
| $2.97M | 3.45% |
624,022
| – | – |
|
9
TScan Therapeutics
TCRX
$60.3M
| $2.88M | 3.35% |
2,087,139
| – | – |
|
|
10
Delcath Systems
DCTH
$455M
| $2.26M | 2.63% |
177,600
+160,600
| +945% | +$2.28M |
|
11
Syndax Pharmaceuticals
SNDX
$2.08B
| $2.25M | 2.62% |
183,259
| – | – |
|
12
Zevra Therapeutics
ZVRA
$766M
| $1.35M | 1.57% |
179,874
| – | – |
|
|
13
Milestone Pharmaceuticals
MIST
$158M
| $1.16M | 1.35% |
+1,451,557
| New | +$2.89M |
|
|
14
Compass Therapeutics
CMPX
$385M
| $434K | 0.5% |
+228,317
| New | +$607K |
|
|
LONA
15
LeonaBio Inc
LONA
$80.1M
| $425K | 0.49% |
149,279
| – | – |
|
|
EIGR
16
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
| $423K | 0.49% |
146,381
| – | – |
|
|
17
Ardelyx
ARDX
$1.31B
| – | – |
-950,947
| Closed | -$4.82M |
|
|
CMPS
18
Compass Pathways
CMPS
$1.8B
| – | – |
-25,209
| Closed | -$95.3K |
|
19
Jasper Therapeutics
JSPR
$19.4M
| – | – |
-20,000
| Closed | -$428K |
|
|
20
Kura Oncology
KURA
$1.01B
| – | – |
-130,000
| Closed | -$1.13M |
|
|
21
Kymera Therapeutics
KYMR
$9.39B
| – | – |
-56,359
| Closed | -$2.27M |
|
Similar funds
OS
OC
JF
1L
USWIA
AWP
RWM
EWA